StockData
Retension Pharmaceuticals, Inc. logo

Retension Pharmaceuticals, Inc. (RTSN) stock

RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.27+0.02 (+0.16%)

Close on Nov 13, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$12.25
Open
$12.30
Day's range
$11.37 – $12.70
Volume
124,992
Average volume (20 days)
114,240

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodRTSNS&P 500DifferenceRTSN per yearS&P 500 per year
1 month+5.5%-3.0%+8.5 pts

Retension Pharmaceuticals stock: common questions

What is Retension Pharmaceuticals's stock price?

RTSN closed at $12.27 on Nov 13, 2026, up 0.16% on the day.

Does Retension Pharmaceuticals pay a dividend?

No. Retension Pharmaceuticals has not paid a cash dividend over the last twelve months.

Who are Retension Pharmaceuticals's competitors?

Companies most similar to Retension Pharmaceuticals by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.

See a number that looks wrong?